We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Neutrophil Enzyme Digests Carbon Nanotubes

By LabMedica International staff writers
Posted on 19 Apr 2010
Researchers have found that the human neutrophil enzyme myeloperoxidase (hMPO) is able to breakdown and detoxify carbon nanotubes, a finding that paves the way for their use as a drug delivery mechanism.

Investigators at the University of Pittsburgh (PA, USA) and colleagues from several other institutions exposed carbon nanotubes to myeloperoxidase in vitro, in neutrophil cultures, and in macrophage cultures. More...
To increase the uptake of the nanotubes by neutrophils they were first coated with immunoglobulins.

Results reported in the April 4, 2010, online edition of the journal Nature Nanotechnology showed that incubation of single-walled nanotubes with hMPO and hydrogen peroxide resulted in degeneration of the nanotubes within 24 hours. This process could be accelerated by the addition of sodium chloride, which generated hypochlorite, a strong oxidizing compound known to break down nanotubes.

Native or immunoglobulin-coated nanotubes were introduced into neutrophil or macrophage cell cultures. After 12 hours in the neutrophil culture, essentially all the coated nanotubes were degraded as compared to only about 30% of the native nanotubes. In contrast, after two days in the macrophage culture only about 50% percent of the coated nanotubes had degenerated. The biodegraded nanotubes did not generate an inflammatory response when aspirated into the lungs of mice.

"The successful medical application of carbon nanotubes relies on their effective breakdown in the body, but carbon nanotubes also are notoriously durable,” said first author Dr. Valerian Kagan, professor of environmental and occupational health at the University of Pittsburgh. "The ability of hMPO to biodegrade carbon nanotubes reveals that this breakdown is part of a natural inflammatory response. The next step is to develop methods for stimulating that inflammatory response and reproducing the biodegradation process inside a living organism.”

Related Links:
University of Pittsburgh



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Urine Analyzer
respons® UDS100
New
Gold Member
POCT RT-qPCR Analyzer
BG-X6
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.